ARCHIVES

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

Fermilab Treats 1,000th Patient

August 7, 1981

Five Investigations Probe NIH Radiation Contamination

November 17, 1995

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

NCI Proposed 1980 Budget Increases R01 Grants By $50 Million Over ’79; Total – $1.055 Billion

June 9, 1978

NCI Will Encourage More Activity In Environment Carcinogenesis

June 21, 1974

Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023

December 13, 2013